OLED Stock Analysis: Universal Display | NASDAQ
Electronic Components | NASDAQ, USA | Market Cap: 3.946m USD | 12M Return: -39.7% | US91347P1057 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 64.6M
EPS Trend: 14.7%
Qual. Beats: 0
Rev. Trend: 51.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Universal Display Corporation (NASDAQ: OLED) researches, develops, and commercializes organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. Classified within the GICS Semiconductors sub-industry, the company operates through a model that combines the sale of proprietary emitter materials with licensing of its patented OLED technology to display manufacturers.
Its main offerings include phosphorescent OLED (PHOLED) technologies sold under the UniversalPHOLED brand, flexible OLED (FOLED) solutions, and OVJP (organic vapor jet printing) technology. Beyond materials, the company provides technology development and support services, contract chemical synthesis research for non-OLED applications, and intellectual property and technology licensing arrangements.
Universal Display was incorporated in 1985 and is headquartered in Ewing, New Jersey. It operates as a mid-cap U.S. company with activities in the United States, South Korea, China, Japan, and other international markets. OLED technology is widely used across the consumer electronics sector, including smartphones, televisions, and wearable devices.
- Apple OLED adoption in iPad and MacBook expands addressable market
- Samsung Display and BOE panel shipments drive material revenue
- Chinese and Korean materials suppliers intensify pricing competition
| Net Income: 195.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.59 > 1.0 |
| NWC/Revenue: 136.9% < 20% (prev 133.7%; Δ 3.19% < -1%) |
| CFO/TA 0.14 > 3% & CFO 262.2m > Net Income 195.7m |
| Net Debt (-454.4m) to EBITDA (257.5m): -1.76 < 3 |
| Current Ratio: 8.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.7m) vs 12m ago -2.08% < -2% |
| Gross Margin: 75.33% > 18% (prev 77.27%; Δ -1.93% > 0.5%) |
| Asset Turnover: 31.78% > 50% (prev 34.27%; Δ -2.49% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.44 (Total Current Assets 941.8m - Total Current Liabilities 110.8m) / Total Assets 1.89b |
| B: 0.60 (Retained Earnings 1.13b / Total Assets 1.89b) |
| C: 0.11 (EBIT TTM 206.8m / Avg Total Assets 1.91b) |
| D: 8.26 (Book Value of Equity 1.68b / Total Liabilities 203.8m) |
| Altman-Z'' = 14.24 = AAA |
| DSRI: 0.94 (Receivables 126.2m/147.0m, Revenue 606.9m/662.0m) |
| GMI: 1.03 (GM 77.27% / 75.33%) |
| AQI: 1.06 (AQ_t 0.38 / AQ_t-1 0.36) |
| SGI: 0.92 (Revenue 606.9m / 662.0m) |
| TATA: -0.04 (NI 195.7m - CFO 262.2m) / TA 1.89b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of August 25, 2026, the stock is trading at USD 84.71 with a total of 612,591 shares traded. Over the past week, the price has changed by -2.23%, over one month by +6.86%, over three months by -8.78% and over the past year by -39.67%.
Current recommended Stop Loss: 80.50 (which is 5% or 1.4 ATR below the current price).
Universal Display has received a consensus analysts rating of 4.10. Therefore, it is recommended to buy OLED.
- StrongBuy: 4
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 115.4 | 36.2% |
P/E Trailing = 20.7343
P/E Forward = 17.6367
P/S = 6.5015
P/B = 2.3432
P/EG = 1.2266
Revenue TTM = 606.9m USD
EBIT TTM = 206.8m USD
EBITDA TTM = 257.5m USD
Long Term Debt = unknown (none)
Short Term Debt = 4.75m USD (from shortTermDebt, last fiscal year)
Debt = 16.9m USD (from shortLongTermDebtTotal, last quarter) (leases 16.9m already included)
Net Debt = -454.4m USD (calculated: Debt 16.9m - CCE 471.3m)
Enterprise Value = 3.49b USD (3.95b + Debt 16.9m - CCE 471.3m)
Interest Coverage Ratio = unknown (Ebit TTM 206.8m / Interest Expense TTM 0.0)
EV/FCF = 20.54x (Enterprise Value 3.49b / FCF TTM 170.0m)
FCF Yield = 4.87% (FCF TTM 170.0m / Enterprise Value 3.49b)
FCF Margin = 28.01% (FCF TTM 170.0m / Revenue TTM 606.9m)
Net Margin = 32.24% (Net Income TTM 195.7m / Revenue TTM 606.9m)
Gross Margin = 75.33% ((Revenue TTM 606.9m - Cost of Revenue TTM 149.7m) / Revenue TTM)
Gross Margin QoQ = 75.82% (prev 74.60%)
Tobins Q-Ratio = 1.85 (Enterprise Value 3.49b / Total Assets 1.89b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 16.9m)
Taxrate = 17.47% (41.4m / 237.1m)
NOPAT = 170.7m (EBIT 206.8m * (1 - 17.47%))
Current Ratio = 8.50 (Total Current Assets 941.8m / Total Current Liabilities 110.8m)
Debt / Equity = 0.01 (Debt 16.9m / totalStockholderEquity, last quarter 1.68b)
Debt / EBITDA = -1.76 (Net Debt -454.4m / EBITDA 257.5m)
Debt / FCF = -2.67 (Net Debt -454.4m / FCF TTM 170.0m)
Total Stockholder Equity = 1.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.25% (Net Income 195.7m / Total Assets 1.89b)
RoE = 11.35% (Net Income TTM 195.7m / Total Stockholder Equity 1.72b)
RoCE = 11.64% (EBIT 206.8m / Capital Employed (Total Assets 1.89b - Current Liab 110.8m))
RoIC = 9.74% (NOPAT 170.7m / Invested Capital 1.75b)
WACC = 10.50% (E(3.95b)/V(3.96b) * Re(10.54%) + D(16.9m)/V(3.96b) * Rd(0.0%) * (1-Tc(0.17)))
Discount Rate = 10.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -63.38 | Cagr: -0.89%
[DCF] Terminal Value 71.35% ; FCFF base≈159.3m ; Y1≈182.6m ; Y5≈268.8m
[DCF] Fair Price = 73.67 (EV 2.93b - Net Debt -454.4m = Equity 3.39b / Shares 46.0m; r=10.50% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 14.68 | EPS CAGR: 1.13% | SUE: 0.08 | # QB: 0
Revenue Correlation: 51.37 | Revenue CAGR: 2.51% | SUE: -0.41 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.14 | Chg30d=-0.26% | Revisions=+12% | Analysts=5
EPS current Year (2026-12-31): EPS=4.20 | Chg30d=-2.59% | Revisions=-38% | GrowthEPS=-17.4% | GrowthRev=-3.1%
EPS next Year (2027-12-31): EPS=4.73 | Chg30d=-4.69% | Revisions=-62% | GrowthEPS=+12.8% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: -39% (up=4, down=11)